Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal candidiasis.

P Brian Smith1, William J Steinbach, Daniel K Benjamin

  • 1Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA.

Infectious Disease Clinics of North America
|August 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variation of caffeine use in late preterm infants in U.S. NICUs over time: A 12-year cohort study.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

Population Pharmacokinetics and Dosing Simulations of Pentobarbital in the Pediatric Population.

Journal of clinical pharmacology·2026
Same author

Conducting multicenter trials through the trial innovation network comprehensive consultation.

Contemporary clinical trials·2026
Same author

Population Pharmacokinetics and Exposure-Safety Analysis of Furosemide in Preterm Infants.

Journal of clinical pharmacology·2026
Same author

Evaluating the duration of post-discontinuation therapeutic ampicillin exposures in preterm infants.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

Pharmacokinetics, safety and preliminary efficacy study of montelukast in critically ill infants with developing bronchopulmonary dysplasia (PRISM).

Contemporary clinical trials communications·2026
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Invasive fungal infections are common and fatal in very low birth weight neonates (<750g). This study explores antifungal prophylaxis and treatment, addressing unknown pharmacokinetics, safety, and efficacy in this vulnerable population.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Invasive fungal infections pose a significant threat to neonates weighing less than 750 grams.
  • These infections are often fatal in extremely low birth weight (ELBW) infants.
  • Limited data exists on antifungal use in this specific ELBW population.

Purpose of the Study:

  • To investigate antifungal prophylaxis and treatment strategies for neonates weighing less than 750g.
  • To evaluate the pharmacokinetics, safety, and efficacy of antifungal agents in ELBW infants.
  • To address knowledge gaps in optimal antifungal product selection and treatment protocols for this high-risk group.

Main Methods:

  • Observational study design.
  • Analysis of existing clinical data on antifungal use in ELBW neonates.

Related Experiment Videos

  • Pharmacokinetic and safety assessments of commonly used antifungal agents.

    • Main Results:

    • Invasive fungal infections are a leading cause of mortality in ELBW neonates.
    • Pharmacokinetics, safety, and efficacy data for antifungal products in this population are largely unknown.
    • Optimal treatment strategies and product choices require further investigation.

    Conclusions:

    • There is a critical need for research into antifungal prophylaxis and treatment in neonates weighing less than 750g.
    • Further studies are essential to establish evidence-based guidelines for antifungal use in ELBW infants.
    • Understanding pharmacokinetics and safety is crucial for improving outcomes in this vulnerable group.